Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade
Conditions: Breast Cancer; HER2-positive Breast Cancer Interventions: Drug: PHESGO Sponsors: Latin American Cooperative Oncology Group; Roche Pharma AG; Oncocl ínicas Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | HER2 | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pharmaceuticals | Research